Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.

Abstract

Few effective regimens are available for patients with advanced multiple myeloma resistant to or relapsing after both alkylating agents and VAD. We treated 52 patients with advanced and refractory multiple myeloma with the combination of cyclophosphamide (3.0 g/m2) and etoposide (900 mg/m2) followed by GM-CSF at a daily dose of 0.125 mg/m2 until recovery of… (More)

Topics

Cite this paper

@article{Dimopoulos1993CyclophosphamideAE, title={Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.}, author={M. A. Dimopoulos and Kay B Delasalle and R. E. Champlin and Raymond Alexanian}, journal={British journal of haematology}, year={1993}, volume={83 2}, pages={240-4} }